Predominant role of peripheral catecholamines in the stress-induced modulation of CYP1A2 inducibility by benzo(alpha)pyrene

Basic Clin Pharmacol Toxicol. 2008 Jan;102(1):35-44. doi: 10.1111/j.1742-7843.2007.00154.x. Epub 2007 Oct 31.

Abstract

The potential involvement of catecholamines and in particular of alpha(2)-adrenoceptor-related signalling pathways, in the regulation of drug-metabolizing enzymes by stress was investigated in Wistar rats after exposure to the environmental pollutant benzo(alpha)pyrene. For this purpose, total cytochrome P450 content, the CYP1A2 mRNA levels, 7-methoxyresorufin-O-dealkylase (MROD), 7-pentoxyresorufin-O-dealkylase (PROD) and p-nitrophenol hydroxylase activity levels were determined in the livers of rats exposed to repeated restraint stress after treatment with benzo(alpha)pyrene coupled with pharmacological manipulations of peripheral and/or central catecholamines and alpha(2)-adrenoceptors. The data show that stress is a significant factor in the regulation of CYP1A2 induction and that catecholamines play a central role in the stress-mediated modulation of hepatic CYP1A2 inducibility by benzo(alpha)pyrene. The up-regulating effect of stress on benzo(alpha)pyrene-induced CYP1A2 gene expression was eliminated after a generalized catecholamine depletion with reserpine. Similarly, in a state where only peripheral catecholamines were depleted and central catecholamines remained intact after guanethidine administration, the up-regulating effect of stress was eliminated. It is apparent that stress up-regulates the induction of CYP1A2 by benzo(alpha)pyrene mainly via peripheral catecholamines, while central catecholamines hold a minor role in the regulation. Pharmacological manipulations of alpha(2)-adrenoceptors appear to interfere with the effect of stress on the regulation of CYP1A2 inducibility. Either blockade or stimulation of alpha(2)-adrenoceptors with atipamezole and dexmedetomidine respectively, eliminated the up-regulating effect of stress on CYP1A2 benzo(alpha)pyrene-induced expression, while it enhanced MROD activity. In contrast, stress and pharmacological manipulations of catecholamines and alpha(2)-adrenoceptors did not affect total P450 content, the CYP2B1/2-dependent PROD and the CYP2E1-dependent p-nitrophenol hydroxylase activities. In conclusion, stress is a significant factor in the regulation of the CYP1A2 inducibility by benzo(alpha)pyrene, which in turn is involved in the metabolism of a large spectrum of toxicants, drugs and carcinogenic agents. Although the mechanism underlying the stress effect on CYP1A2 induction has not been clearly elucidated, it appears that peripheral catecholamines hold a predominant role, while central catecholamines and in particular, central noradrenergic pathways hold a minor role.

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Benzo(a)pyrene / pharmacology*
  • Catecholamines / metabolism*
  • Cytochrome P-450 CYP1A2 / biosynthesis*
  • Cytochrome P-450 CYP1A2 / genetics
  • Dexmedetomidine / pharmacology
  • Drug Therapy, Combination
  • Environmental Pollutants / pharmacology*
  • Enzyme Induction / drug effects
  • Gene Expression Regulation, Enzymologic / drug effects
  • Guanethidine / pharmacology
  • Imidazoles / pharmacology
  • Injections, Intraperitoneal
  • Male
  • Microsomes, Liver / drug effects
  • Microsomes, Liver / enzymology
  • Rats
  • Rats, Wistar
  • Receptors, Adrenergic, alpha-2 / metabolism
  • Reserpine / pharmacology
  • Restraint, Physical
  • Stress, Physiological / enzymology*

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Catecholamines
  • Environmental Pollutants
  • Imidazoles
  • Receptors, Adrenergic, alpha-2
  • atipamezole
  • Benzo(a)pyrene
  • Dexmedetomidine
  • Reserpine
  • Cytochrome P-450 CYP1A2
  • Guanethidine